Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A

摘要

To assess the impact of botulinum toxin type A (BTX-A) on signs and symptoms of dry eye (DE) in affected eye of hemifacial spasm (HFS) patients and to compare the prevalence of DE between affected and non-affected eye in HFS patients.